跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT06204354
NCT06204354尚未招募不适用

Construction of Gynecological Tumor Sample Library

Peking Union Medical College Hospital0 个研究点目标入组 2,500 人开始时间: 2024年1月最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
2,500
主要终点
construction of Biobank
研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

Constructing a gynecological tumor samples library, which is open and can be accessed.

详细描述

This project is the construction and maintenance of a gynecological tumor sample library. It is supported by the National Key Laboratory of Difficult, Severe, and Rare Diseases at Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences. This project will lay a clinical specimen foundation for exploring the molecular mechanisms of gynecological tumors in the future.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years（Adult, Older Adult）
性别
Female
接受健康志愿者
否

入选标准

  • •An informed consent form was obtained. If the age is less than 18 years old, the consent form should be signed by the guardian.
  • •Preoperative tumor burden assessment and intraoperative evaluation by the supervising physician (professor) suggest sampling is acceptable.
  • •The research team believes that sampling is possible.
  • •Having the relevant requirements for sample library storage.
  • •Surgical treatment is performed at Peking Union Medical College Hospital.

排除标准

  • •Not meeting all inclusion criteria.
  • •The research team considers any circumstances or considerations that may hinder normal pathological evaluation.

结局指标

主要结局

construction of Biobank

时间窗: 3 years

Biobank including gynecolgic cancer samples, including cervical cancer, endometrial cancer, ovarian cancer, vulva cancer, vaginal cancer, and others types

次要结局

  • Exploring the molecular mechanism based on biobank(3 year)
  • Drug sensitivity detection based on biobank(3 year)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

尚未招募
不适用
Construction of Gynecological Tumor OrganoidsGynecologic CancerOrganoid
NCT06155370Peking Union Medical College Hospital200
Unknown
不适用
Tissue Bank of Biological Specimens From Patients With Gynecologic DiseaseEndometrial NeoplasmsUterine Cervical NeoplasmsOvarian NeoplasmsLeiomyoma
NCT00299481U.S. Army Medical Research and Development Command7,000
已完成
不适用
Collecting Tumor Samples From Patients With Gynecological TumorsBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedChildhood Embryonal RhabdomyosarcomaChildhood Malignant Ovarian Germ Cell TumorEndometrioid Stromal SarcomaGestational Trophoblastic TumorMalignant MesotheliomaMalignant Ovarian Epithelial TumorNeoplasm of Uncertain Malignant PotentialOvarian Brenner TumorOvarian Clear Cell CystadenocarcinomaOvarian Serous CystadenocarcinomaPaget Disease of the VulvaMelanomaRecurrent Cervical CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Ovarian Germ Cell TumorRecurrent Primary Peritoneal CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Vaginal CarcinomaRecurrent Vulvar CarcinomaStage I Ovarian CancerStage I Uterine Corpus CancerStage I Vaginal CancerStage I Vulvar CancerStage IA Cervical CancerStage IA Fallopian Tube CancerStage IA Ovarian CancerStage IA Ovarian Germ Cell TumorStage IB Cervical CancerStage IB Fallopian Tube CancerStage IB Ovarian CancerStage IB Ovarian Germ Cell TumorStage IC Fallopian Tube CancerStage IC Ovarian CancerStage IC Ovarian Germ Cell TumorStage II Ovarian CancerStage II Uterine Corpus CancerStage II Vaginal CancerStage II Vulvar CancerStage IIA Cervical CancerStage IIA Fallopian Tube CancerStage IIA Ovarian CancerStage IIA Ovarian Germ Cell TumorStage IIB Cervical CancerStage IIB Fallopian Tube CancerStage IIB Ovarian CancerStage IIB Ovarian Germ Cell TumorStage IIC Fallopian Tube CancerStage IIC Ovarian CancerStage IIC Ovarian Germ Cell TumorStage III Borderline Ovarian Surface Epithelial-Stromal TumorStage III Cervical CancerStage III Uterine Corpus CancerStage III Vaginal CancerStage III Vulvar CancerStage IIIA Fallopian Tube CancerStage IIIA Ovarian CancerStage IIIA Ovarian Germ Cell TumorStage IIIA Primary Peritoneal CancerStage IIIB Fallopian Tube CancerStage IIIB Ovarian CancerStage IIIB Ovarian Germ Cell TumorStage IIIB Primary Peritoneal CancerStage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Ovarian Germ Cell TumorStage IIIC Primary Peritoneal CancerStage IV Borderline Ovarian Surface Epithelial-Stromal TumorStage IV Fallopian Tube CancerStage IV Ovarian CancerStage IV Primary Peritoneal CancerStage IV Uterine Corpus CancerStage IVA Cervical CancerStage IVA Vaginal CancerStage IVB Cervical CancerStage IVB Vaginal CancerStage IVB Vulvar CancerUterine Corpus CancerUterine Corpus LeiomyosarcomaVulvar Squamous Cell Carcinoma
NCT00897442Gynecologic Oncology Group275
已完成
不适用
Pre-Clinical Models in Gynecological Tumors A Tissue RepositoryEndometrial NeoplasmsUterine Neoplasms
NCT00250783University of New Mexico26
招募中
不适用
Establishment of a Tumor Bank for Tissue SamplesOvarian NeoplasmsBreast NeoplasmsNeoplasms of the Female GenitaliaLung NeoplasmsEndocrine Gland NeoplasmsColorectal Neoplasms
NCT01789229Medical University of Vienna10,000